These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 15255086

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, Verbrugge RR, Burckart GJ, Lesko LJ.
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [Abstract] [Full Text] [Related]

  • 3. A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility.
    Matlock A, Allan N, Wills B, Kang C, Leikin JB.
    Clin Toxicol (Phila); 2011 Jul; 49(6):443-7. PubMed ID: 21591886
    [Abstract] [Full Text] [Related]

  • 4. FDA boxed warnings: how to prescribe drugs safely.
    O'Connor NR.
    Am Fam Physician; 2010 Feb 01; 81(3):298-303. PubMed ID: 20112888
    [Abstract] [Full Text] [Related]

  • 5. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
    Murphy S, Roberts R.
    J Allergy Clin Immunol; 2006 Jan 01; 117(1):34-9. PubMed ID: 16387581
    [Abstract] [Full Text] [Related]

  • 6. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
    Fed Regist; 1997 Jul 31; 62(147):41061-3. PubMed ID: 10169832
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Primary care physicians' use of FDA-approved prescription drug labels.
    Sullivan HW, O'Donoghue AC, Aikin KJ.
    J Am Board Fam Med; 2014 Jul 31; 27(5):694-8. PubMed ID: 25201939
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
    Olfson M, Marcus SC, Druss BG.
    Arch Gen Psychiatry; 2008 Jan 31; 65(1):94-101. PubMed ID: 18180433
    [Abstract] [Full Text] [Related]

  • 16. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
    Wang LM, Wong M, Lightwood JM, Cheng CM.
    Ann Pharmacother; 2010 Jan 31; 44(1):28-34. PubMed ID: 20040698
    [Abstract] [Full Text] [Related]

  • 17. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
    Willke RJ, Burke LB, Erickson P.
    Control Clin Trials; 2004 Dec 31; 25(6):535-52. PubMed ID: 15588741
    [Abstract] [Full Text] [Related]

  • 18. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Dec 11; 68(238):69009-20. PubMed ID: 14672084
    [Abstract] [Full Text] [Related]

  • 19. The Physicians' Desk Reference. Problems and possible improvements.
    Cohen JS, Insel PA.
    Arch Intern Med; 1996 Jul 08; 156(13):1375-80. PubMed ID: 8678706
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.